OTC Markets Group Comments on First Canadian-listed Regulation A+ Offering on OTCQB
At the end of January, True Leaf Medicine International Ltd. (OTCQB: TRLFF) became the First Canadian-listed Regulation A+ Offering on the OTCQB Venture Market.
In a press release, Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group and Richard Carleton, CEO of the Canadian Securities Exchange commented on this exciting first.
Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group said “We congratulate True Leaf on a successful Reg A+ offering and the expansion of its unique profile to a broader pool of American investors. True Leaf’s $14 million (CAD) Reg A+ offering and private placement demonstrate the quality and effectiveness of both our premium OTCQX and OTCQB Venture markets in facilitating an effective capital raise. This presents tremendous benefits for small-cap, entrepreneurial and emerging sector companies seeking to raise capital–tailoring the needs of being a public company, while providing a cost-effective, less burdensome alternative to a national exchange listing.”
Richard Carleton, CEO of the Canadian Securities Exchange where True Leaf is listed in Canada, said “Access to US investors at an attractive cost through Reg A+ is a key advantage for Canadian reporting issuers. The True Leaf Reg A+ financing should serve as an important model for their peers.”
Learn more HERE.